Single-center experience with liver transplantation from controlled non-heartbeating donors: a viable source of grafts.

PubWeight™: 0.93‹?›

🔗 View Article (PMC 1409859)

Published in Ann Surg on November 01, 2005

Authors

Paolo Muiesan1, Raffaele Girlanda, Wayel Jassem, Hector Vilca Melendez, John O'Grady, Matthew Bowles, Mohamed Rela, Nigel Heaton

Author Affiliations

1: Department of Liver Transplantation and HPB Surgery, King's College Hospital, London, UK. paolo.muiesan@kingsch.nhs.uk

Articles citing this

Therapeutic liver reconstitution with murine cells isolated long after death. Gastroenterology (2010) 1.78

Liver Transplantation: East versus West. J Clin Exp Hepatol (2013) 0.89

Utilization of expanded criteria donors in liver transplantation. Int J Organ Transplant Med (2013) 0.83

Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open (2013) 0.83

Prediction of survival after liver transplantation for chronic severe hepatitis B based on preoperative prognostic scores: a single center's experience in China. World J Surg (2009) 0.81

Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature. J Clin Exp Hepatol (2013) 0.80

Liver transplantation from a non-heart-beating donor after pulmonary failure: report of a case. Surg Today (2009) 0.79

Donation after cardio-circulatory death liver transplantation. World J Gastroenterol (2012) 0.78

Lipidomics comparing DCD and DBD liver allografts uncovers lysophospholipids elevated in recipients undergoing early allograft dysfunction. Sci Rep (2015) 0.77

Challenges in machine perfusion preservation for liver grafts from donation after circulatory death. Transplant Res (2013) 0.77

Recent advances in liver transplantation for the practicing gastroenterologist. Gastroenterol Hepatol (N Y) (2009) 0.76

Successful auto-implantation of hepatic cells in lung tissue: An animal study. J Res Med Sci (2013) 0.75

Acute kidney injury and post-reperfusion syndrome in liver transplantation. World J Gastroenterol (2016) 0.75

Developing a donation after cardiac death risk index for adult and pediatric liver transplantation. World J Transplant (2017) 0.75

Articles cited by this

Kidney transplantation from donors without a heartbeat. N Engl J Med (2002) 4.85

Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation (2003) 2.63

Categories of non-heart-beating donors. Transplant Proc (1995) 2.23

Survival following liver transplantation from non-heart-beating donors. Ann Surg (2004) 1.96

Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83

Successful extrarenal transplantation from non-heart-beating donors. Transplantation (1995) 1.53

A case-control comparison of the results of renal transplantation from heart-beating and non-heart-beating donors. Transplantation (2001) 1.52

Warm preflush with streptokinase improves microvascular procurement and tissue integrity in liver graft retrieval from non-heart-beating donors. Transplantation (2000) 1.47

Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg (2001) 1.40

Renal transplantation from non-heart beating donors: a promising alternative to enlarge the donor pool. J Am Soc Nephrol (2000) 1.32

Liver transplantation from controlled non-heart-beating donors. Surgery (2000) 1.32

Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update. Transplantation (2000) 1.13

Liver and kidney preservation by perfusion. Lancet (2002) 0.97

Comparative study of the use of systolic and asystolic kidney donors between 1988 and 1991. The South Thames Transplant Group. Transplant Proc (1993) 0.85

Use of thrombolytic streptokinase as a preflush in the NHBD procurement. Transplant Proc (2003) 0.83

Time is of the essence: the pressing need for comprehensive non-heart-beating cadaveric donation policies. Transplant Proc (1995) 0.82

Effect on outcome of the lengthening waiting list for liver transplantation. Gut (2000) 0.82

Early results of a non-heartbeating donor (NHBD) programme with machine perfusion. Transpl Int (2000) 0.81

Non beating heart donors as a possible source for liver transplantation. Acta Chir Belg (2001) 0.80

Successful segmental auxiliary liver transplantation from a non-heart-beating donor: implications for split-liver transplantation. Transplantation (2003) 0.80

The fate of 359 renal allografts harvested from non-heart beating cadaver donors at a single center. Clin Transpl (1998) 0.79

Articles by these authors

Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med (2015) 3.47

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis. Lancet (2014) 3.12

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91

Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81

Providing treatment to prisoners with mental disorders: development of a policy. Selective literature review and expert consultation exercise. Br J Psychiatry (2003) 2.79

Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23

Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis (2003) 2.17

Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol (2012) 2.15

Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl (2013) 2.05

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00

Increasing burden of liver disease in patients with HIV infection. Lancet (2011) 1.98

Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol (2013) 1.83

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut (2010) 1.83

Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. J Hepatol (2005) 1.79

Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol (2011) 1.74

Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol (2012) 1.66

Liver histology and progression of fibrosis in individuals with chronic hepatitis C and persistently normal ALT. Am J Gastroenterol (2003) 1.63

One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62

Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl (2005) 1.60

Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58

Character and temporal evolution of apoptosis in acetaminophen-induced acute liver failure*. Crit Care Med (2013) 1.51

Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transpl (2013) 1.48

Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47

Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47

Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47

Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45

Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45

Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45

Diaphragmatic dysfunction after pediatric orthotopic liver transplantation. Transplantation (2002) 1.43

Death of a living liver donor: opening Pandora's box. Liver Transpl (2013) 1.43

Live organ-donation for islet transplantation. Lancet (2005) 1.40

Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg (2004) 1.39

Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS study. Eur J Cancer (2011) 1.29

Human plasma fibrinogen is synthesized in the liver. Blood (2006) 1.27

Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25

Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry (2008) 1.18

Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18

Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl (2008) 1.15

The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15

Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? Transplantation (2015) 1.13

Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13

Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12

Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem (2005) 1.11

Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl (2006) 1.10

Pseudoaneurysm following laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int (2007) 1.10

Emergency liver transplantation following severe liver trauma. Liver Transpl (2008) 1.09

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08

Liver transplantation for HCV-related cirrhosis in a patient with gastric mucosa-associated lymphoma (MALToma) pretreated with rituximab. Liver Transpl (2005) 1.08

Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Hepatobiliary Pancreat Dis Int (2007) 1.08

Selective embolization for bleeding visceral artery pseudoaneurysms in patients with pancreatitis. Hepatobiliary Pancreat Dis Int (2010) 1.07

How we treat sickle hepatopathy and liver transplantation in adults. Blood (2014) 1.07

The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation (2004) 1.07

Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation (2003) 1.06

Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl (2004) 1.04

Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation. Liver Transpl (2011) 1.01

Graft positioning at liver transplantation in situs inversus. Liver Transpl (2006) 1.01

Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant (2003) 1.00

Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol (2008) 1.00

Immunosuppression minimization vs. complete drug withdrawal in liver transplantation. J Hepatol (2013) 0.99

Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl (2010) 0.98

Auxiliary liver transplantation for acute liver failure in children. Ann Surg (2010) 0.98

Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet (2005) 0.98

Hydrodynamic gene delivery to the liver: theoretical and practical issues for clinical application. Curr Gene Ther (2009) 0.97

Evidence for the presence of stem cell-like progenitor cells in human adult pancreas. J Endocrinol (2007) 0.96

Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation (2006) 0.96

Results of split liver transplantation in children. Ann Surg (2002) 0.96

Laparoscopic versus open left lateral segmentectomy. BMC Surg (2009) 0.96

Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol (2005) 0.96